Clinical predictors of advanced fibrosis in patient with non-alcoholic fatty liver disease (NAFLD)

被引:0
|
作者
Siua, W. [1 ,2 ]
Andiganib, M. [1 ,2 ]
Frasera, A. [1 ,2 ]
Vijayana, B. [1 ,2 ]
Mclemana, L. [1 ,2 ]
Englisha, S. [1 ,2 ]
Mukhopadhyaa, A. [1 ,2 ]
机构
[1] Aberdeen Royal Infirm, Aberdeen, Scotland
[2] Univ Aberdeen, Aberdeen, Scotland
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P-0861
引用
收藏
页码:187 / 187
页数:1
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
  • [42] Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
    Daher, Saleh
    Cohen, Namma Lev
    Massarwa, Muhammad
    Mahamid, Mahmud
    Nasser, Mira
    Hazou, Wadi
    Oren, Rani
    Safadi, Rifaat
    Khoury, Tawfik
    PLOS ONE, 2018, 13 (11):
  • [43] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Rockstroh, Juergen Kurt
    CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
  • [44] Comparison of transient elastography and NAFLD fibrosis score in non-alcoholic fatty liver disease
    Wu, Y.
    Weltman, M.
    Eslick, G. D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 100 - 100
  • [45] Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Burra, Patrizia
    Bizzaro, Debora
    Gonta, Anna
    Shalaby, Sarah
    Gambato, Martina
    Morelli, Maria Cristina
    Trapani, Silvia
    Floreani, Annarosa
    Marra, Fabio
    Brunetto, Maurizia Rossana
    Taliani, Gloria
    Villa, Erica
    LIVER INTERNATIONAL, 2021, 41 (08) : 1713 - 1733
  • [46] Clinical Predictors of Recurrent Non-Alcoholic Steatohepatitis Following Liver Transplantation for Non-Alcoholic Fatty Liver Disease
    Stein, L.
    Dunn, W.
    Nguyen, H.
    Bhasin, D.
    Pollinger, H.
    Johnson, M.
    Shrestha, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 703 - 703
  • [47] Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
    Alejandro Campos-Murguía
    Astrid Ruiz-Margáin
    José A González-Regueiro
    Ricardo U Macías-Rodríguez
    World Journal of Gastroenterology, 2020, (39) : 5919 - 5943
  • [48] Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
    Campos-Murguia, Alejandro
    Ruiz-Margain, Astrid
    Gonzalez-Regueiro, Jose A.
    Macias-Rodriguez, Ricardo U.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (39) : 5919 - 5943
  • [49] Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
    Han, Eugene
    DIABETES & METABOLISM JOURNAL, 2022, 46 (04) : 564 - 566
  • [50] Validation of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV
    Yanavich, C.
    Pacheco, A.
    Cardoso, S.
    Nunes, E.
    Chaves, U.
    Santos, R.
    Morata, M.
    Veloso, V. G.
    Grinsztejn, B.
    Perazzo, H.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 5 - 6